Literature DB >> 26865718

Digging through the Obstruction: Insight into the Epithelial Cell Response to Respiratory Virus Infection in Patients with Cystic Fibrosis.

Matthew R Hendricks1, Jennifer M Bomberger2.   

Abstract

Respiratory virus infections are common but generally self-limiting infections in healthy individuals. Although early clinical studies reported low detection rates, the development of molecular diagnostic techniques by PCR has led to an increased recognition that respiratory virus infections are associated with morbidity and acute exacerbations of chronic lung diseases, such as cystic fibrosis (CF). The airway epithelium is the first barrier encountered by respiratory viruses following inhalation and the primary site of respiratory viral replication. Here, we describe how the airway epithelial response to respiratory viral infections contributes to disease progression in patients with CF and other chronic lung diseases, including the role respiratory viral infections play in bacterial acquisition in the CF patient lung.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2016        PMID: 26865718      PMCID: PMC4836329          DOI: 10.1128/JVI.01864-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Pseudomonas aeruginosa suppresses interferon response to rhinovirus infection in cystic fibrosis but not in normal bronchial epithelial cells.

Authors:  Sangbrita S Chattoraj; Shyamala Ganesan; Andrea Faris; Adam Comstock; Wai-Ming Lee; Umadevi S Sajjan
Journal:  Infect Immun       Date:  2011-08-08       Impact factor: 3.441

2.  Innate inflammatory responses of pediatric cystic fibrosis airway epithelial cells: effects of nonviral and viral stimulation.

Authors:  Erika N Sutanto; Anthony Kicic; Clara J Foo; Paul T Stevens; David Mullane; Darryl A Knight; Stephen M Stick
Journal:  Am J Respir Cell Mol Biol       Date:  2011-02-11       Impact factor: 6.914

3.  Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae colonization in mice.

Authors:  Shigeki Nakamura; Kimberly M Davis; Jeffrey N Weiser
Journal:  J Clin Invest       Date:  2011-08-15       Impact factor: 14.808

4.  Induction of type I interferon signaling by Pseudomonas aeruginosa is diminished in cystic fibrosis epithelial cells.

Authors:  Dane Parker; Taylor S Cohen; Morten Alhede; Bryan S Harfenist; Francis J Martin; Alice Prince
Journal:  Am J Respir Cell Mol Biol       Date:  2012-01       Impact factor: 6.914

Review 5.  The role of viral infections in exacerbations of chronic obstructive pulmonary disease and asthma.

Authors:  Richard Hewitt; Hugo Farne; Andrew Ritchie; Emma Luke; Sebastian L Johnston; Patrick Mallia
Journal:  Ther Adv Respir Dis       Date:  2015-11-26       Impact factor: 4.031

6.  Enhanced adherence of Streptococcus pneumoniae to human epithelial cells infected with respiratory syncytial virus.

Authors:  Jeanne-Marie Hament; Piet C Aerts; Andre Fleer; Hans Van Dijk; Theo Harmsen; Jan L L Kimpen; Tom F W Wolfs
Journal:  Pediatr Res       Date:  2004-04-21       Impact factor: 3.756

7.  Respiratory infections in cystic fibrosis patients caused by virus, chlamydia and mycoplasma--possible synergism with Pseudomonas aeruginosa.

Authors:  N T Petersen; N Høiby; C H Mordhorst; K Lind; E W Flensborg; B Bruun
Journal:  Acta Paediatr Scand       Date:  1981-09

8.  Impaired innate host defense causes susceptibility to respiratory virus infections in cystic fibrosis.

Authors:  Shuo Zheng; Bishnu P De; Suresh Choudhary; Suzy A A Comhair; Tannishia Goggans; Roger Slee; Bryan R G Williams; Joseph Pilewski; S Jaharul Haque; Serpil C Erzurum
Journal:  Immunity       Date:  2003-05       Impact factor: 31.745

9.  Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice.

Authors:  Arash Shahangian; Edward K Chow; Xiaoli Tian; Jason R Kang; Amir Ghaffari; Su Y Liu; John A Belperio; Genhong Cheng; Jane C Deng
Journal:  J Clin Invest       Date:  2009-07       Impact factor: 14.808

10.  Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation.

Authors:  Patrick Mallia; Simon D Message; Vera Gielen; Marco Contoli; Katrina Gray; Tatiana Kebadze; Julia Aniscenko; Vasile Laza-Stanca; Michael R Edwards; Louise Slater; Alberto Papi; Luminita A Stanciu; Onn M Kon; Malcolm Johnson; Sebastian L Johnston
Journal:  Am J Respir Crit Care Med       Date:  2010-10-01       Impact factor: 21.405

View more
  9 in total

1.  Influenza Casts a Lung Shadow.

Authors:  Xavier De Luna; Kevan L Hartshorn
Journal:  Am J Pathol       Date:  2017-02-21       Impact factor: 4.307

2.  Airway Mucosal Host Defense Is Key to Genomic Regulation of Cystic Fibrosis Lung Disease Severity.

Authors:  Deepika Polineni; Hong Dang; Paul J Gallins; Lisa C Jones; Rhonda G Pace; Jaclyn R Stonebraker; Leah A Commander; Jeanne E Krenicky; Yi-Hui Zhou; Harriet Corvol; Garry R Cutting; Mitchell L Drumm; Lisa J Strug; Michael P Boyle; Peter R Durie; James F Chmiel; Fei Zou; Fred A Wright; Wanda K O'Neal; Michael R Knowles
Journal:  Am J Respir Crit Care Med       Date:  2018-01-01       Impact factor: 21.405

Review 3.  Compromised Defenses: Exploitation of Epithelial Responses During Viral-Bacterial Co-Infection of the Respiratory Tract.

Authors:  Jeffrey A Melvin; Jennifer M Bomberger
Journal:  PLoS Pathog       Date:  2016-09-15       Impact factor: 6.823

4.  Novel protective mechanism for interleukin-33 at the mucosal barrier during influenza-associated bacterial superinfection.

Authors:  K M Robinson; K Ramanan; M E Clay; K J McHugh; H E Rich; J F Alcorn
Journal:  Mucosal Immunol       Date:  2017-04-12       Impact factor: 7.313

Review 5.  Surviving Deadly Lung Infections: Innate Host Tolerance Mechanisms in the Pulmonary System.

Authors:  Meredith J Crane; Kayla M Lee; Ethan S FitzGerald; Amanda M Jamieson
Journal:  Front Immunol       Date:  2018-06-22       Impact factor: 7.561

Review 6.  The Virome of the Human Respiratory Tract.

Authors:  Kristine M Wylie
Journal:  Clin Chest Med       Date:  2016-12-10       Impact factor: 2.878

7.  Quantitative Framework for Model Evaluation in Microbiology Research Using Pseudomonas aeruginosa and Cystic Fibrosis Infection as a Test Case.

Authors:  Daniel M Cornforth; Frances L Diggle; Jeffrey A Melvin; Jennifer M Bomberger; Marvin Whiteley
Journal:  mBio       Date:  2020-01-14       Impact factor: 7.867

8.  First Wave of COVID-19 in French Patients with Cystic Fibrosis.

Authors:  Harriet Corvol; Sandra de Miranda; Lydie Lemonnier; Astrid Kemgang; Martine Reynaud Gaubert; Raphael Chiron; Marie-Laure Dalphin; Isabelle Durieu; Jean-Christophe Dubus; Véronique Houdouin; Anne Prevotat; Sophie Ramel; Marine Revillion; Laurence Weiss; Loic Guillot; Pierre-Yves Boelle; Pierre-Régis Burgel
Journal:  J Clin Med       Date:  2020-11-10       Impact factor: 4.241

9.  SARS-CoV-2 (COVID-19) and cystic fibrosis.

Authors:  Bruce A Stanton; Thomas H Hampton; Alix Ashare
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-07-15       Impact factor: 5.464

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.